Medical and Pharmaceutical Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment The stock was up by about 200% during early trading hours Rowan DunneFebruary 6, 2025
AI and Autonomy Korean medical technology company incorporates AI into lung cancer diagnosis Japan has a critical shortage of radiologists, despite a population double the size of Korea's Joseph MortonFebruary 3, 2025
Medical and Pharmaceutical Obesity reduces risk of dying from lung cancer by 21%, South Korean study finds The investigators examined data from more than 7,000 patients over an 11-year period to make this determination Rowan DunneJanuary 30, 2025
AI and Autonomy Median Technologies and European Investment Bank agrees to €37.5M loan The tech leverages machine learning to analyze imaging data generated by low-dose computed tomography Joseph MortonJanuary 28, 2025
Medical and Pharmaceutical South Korean researchers come up with novel treatment option for lung cancer Non-small cell lung cancer constitutes 85 per cent of all lung cancer cases Joseph MortonJanuary 16, 2025
AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024
Health & Wellness GSK small-cell lung cancer drug gets nod from European Medicines Agency Chinese-based Hansoh Pharma is conducting the trial to evaluate GSK'227 in patients with locally advanced or metastatic solid tumours Joseph MortonDecember 17, 2024
Health & Wellness Robotic-assist and other tech spark demand in lung cancer surgery market The key developments are led by advances in robotic-assisted surgical systems and imaging technologies Joseph MortonNovember 25, 2024
Health & Wellness American Lung Association urges high-risk individuals to get lung cancer screening Only 16.0 per cent of eligible individuals underwent lung cancer screening in 2022 Joseph MortonNovember 20, 2024
Health & Wellness Breath Diagnostics onboards new president and closes critical financing Aaron Roebuck brings three decades of experience in respiratory and cardiopulmonary medicine, and commercialization of medical devices Joseph MortonOctober 31, 2024